Valeant Pharmaceuticals Announces 2015 Annual Meeting Results

May 19, 2015

LAVAL, Quebec, May 19, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced the election of eleven directors nominated at its 2015 annual meeting of shareholders today.  The detailed results of the vote for the election of directors are set out below: 

Name


For


Withheld


Broker Non-Votes










Ronald H. Farmer


259,517,209


2,064,596


12,938,661


Colleen A. Goggins


260,564,263


1,017,542


12,938,661


Robert A. Ingram


258,725,145


2,856,660


12,938,661


Anders Lönner


259,632,031


1,949,774


12,938,661


Theo Melas-Kyriazi


260,811,015


770,790


12,938,661


J. Michael Pearson


255,809,687


5,772,118


12,938,661


Robert N. Power


258,849,981


2,731,824


12,938,661


Norma A. Provencio


260,777,276


804,529


12,938,661


Howard B. Schiller


250,437,448


11,144,357


12,938,661


Katharine B. Stevenson


260,656,695


925,110


12,938,661


Jeffrey W. Ubben


260,166,082


1,415,723


12,938,661


 

At the annual meeting, shareholders also approved the non-binding advisory vote on named executive officer compensation as disclosed in the proxy statement and appointed PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm until the close of the Company's 2016 annual meeting of shareholders.

The final vote tabulation on all matters voted on at today's meeting will be reported to the U.S. Securities and Exchange Commission on a current report on Form 8-K and such report will be made available on the Company's web site, www.valeant.com.

About Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology  and branded generics. More information about Valeant can be found at www.valeant.com.

Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com

Valeant Pharmaceuticals International, Inc.

Logo - http://photos.prnewswire.com/prnh/20101025/LA87217LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-announces-2015-annual-meeting-results-300085929.html

SOURCE Valeant Pharmaceuticals International, Inc.

Annual Report

2015 Annual Report

The right products
The right philosophy.
record organic growth.

View All